Cardiac output is a major determinant of the rate of uptake of volatile anaesthetic agents. Theoretical work suggests a 30% change in cardiac output will produce a measurable change in end-tidal volatile agent. We present three patients in whom significant changes in haemodynamic parameters, consistent with a large fall in cardiac output, were accompanied by an increase in end-tidal volatile agent concentrations. The changes in end-tidal volatile agent concentrations were comparable in magnitude but in the opposite direction to the changes in end-tidal CO 2 . Clinically, an unexplained change in end-tidal concentration of a volatile agent may signify a large change in cardiac output.
Cardiac output is a major determinant of the rate of uptake of volatile anaesthetics. Previous modelling 1,2 suggests a change in cardiac output of 30 to 40% will produce a measurable change in end-tidal agent concentrations with the currently used volatile agents. In the following three cases, major haemodynamic changes were accompanied by significant changes in volatile anaesthetic concentrations. The reasons for these changes are discussed and a method for understanding volatile anaesthetic kinetics is proposed.
All patients were monitored with Datex A/S3 (Datex-Ohmeda) systems from which the data was logged and displayed on a laptop computer.
CASE HISTORIES Patient 1
A fit, 40-year-old female was undergoing routine abdominal hysterectomy. During placement of abdominal packs, the pulse rate fell from above 70 beats.min -1 to less than 30 beats.min -1 as shown in Figure 1 . The middle panel of Figure 1 shows the changes that occurred in the end-expired concentration (F E′ ) of isoflurane. Prior to the pulse rate change F E′ was decreasing towards a maintenance level, due to a step reduction in the inspired concentration at time ~10 min. Over the next two minutes F E′ increased 0.06% (an 11% increase) from 0.55% to 0.61%. This change occurred despite the trend at the time being a decline. When the pulse rate rose above 40 beats.min -1 , F E′ isoflurane resumed its earlier decline. During this incident no changes were made in fresh gas flow or vaporizer setting. Figure 1 also shows that during this incident ETCO 2 fell 15% from 38 mmHg to 32 mmHg. ETCO 2 returned to earlier values as the pulse rate increased.
Patient 2
A 39-year-old woman was undergoing lumbar spinal decompression. The case proceeded uneventfully for more than an hour. About 70 minutes into the case, the systolic pressure was recorded as 60 mmHg by a NIBP device ( Figure 2 ). A search for causes revealed 1000 ml of blood in the suction jar which had not been present minutes earlier. Rapid fluid resuscitation was begun and the setting on the sevoflurane vaporizer decreased. Figure 2 shows the rise in end-tidal volatile (sevoflurane) and the fall in ETCO 2 that had been occurring over the seven minutes leading up to the point at which the anaesthetist was alerted by the low blood pressure. The change in both F E′ of sevoflurane and ETCO 2 was approximately 20%.
Patient 3
An 83-year-old woman was undergoing a mastectomy. Following induction of anaesthesia with propofol and fentanyl, she was ventilated with sevoflurane in oxygen and air through a laryngeal mask airway. Figure 3 illustrates the changes occurring in this case. About 22 minutes after induction of anaesthesia, 50 µg fentanyl was administered. This was followed by a decrease in pulse rate from 55 beats.min -1 to less than 30 beats.min -1 . The blood pressure decreased from 135/55 to 78/40 mmHg. The decline in pulse and blood pressure was accompanied by a 15% increase in F E′ sevoflurane from 2.0% to 2.3% over three minutes. This change was obvious on the trend display. ETCO 2 fell 12.5% from 40 mmHg to 35 mmHg. The sevoflurane was turned down and atropine 0.4 mg administered. The pulse rate rose to 60 beats.min -1 and blood pressure to 110/65.
DISCUSSION
Cardiac output is a major determinant of the rate of uptake of volatile anaesthetic agents. The factors producing movement of volatile agents across the alveolar membrane are summarized in equation 1.
Rate of Uptake=
where . Q is the cardiac output, λ b/g is the blood/gas partition coefficient and Fa and Fv are the arterial and mixed venous partial pressures respectively (expressed as fractions of ambient atmospheric 
CASE REPORT
Anaesthesia and Intensive Care, Vol. 29, No. 5, October 2001 pressure). If uptake is assumed to be not limited by diffusion or marked ventilation perfusion mismatch, then F a =F A where F A is the fractional alveolar concentration.
It follows from Equation 1 that a fall in . Q will reduce the rate of uptake. This will lead to a rise in the alveolar concentration since less is being removed from the lung, while, at least initially, the rate of delivery from the circuit to the lung is unchanged. Thus the ratio F E′ : F I will rise. This mechanism is the basis for the effect of a cardiac output change on the traditional F E′ /F I diagram. An additional effect is that as uptake falls, less agent is removed from the circuit, resulting in a rise in F I . This increase in F I will lead to an increase in FA which will tend to drive up both uptake and F E′ .
The three patients presented here demonstrate large haemodynamic changes accompanied by a rise in F E′ volatile and a fall in ETCO 2 . In retrospect, the changes in gas exchange in Patient 2 were observable for some minutes before the haemodynamic change became apparent.
We display volatile anaesthetic concentrations on the Datex A/S3 as a slow trend (approximately five minutes per screen sweep) and also on a computerbased continuous trend display. The nature of these systems and displays often makes changes in volatile anaesthetic concentration more obvious than small changes in ETCO 2 . Improvement in cardiac output with therapy can be confirmed by a rise in ETCO 2 .
There was no quantitative measurement of cardiac output in these cases. We have inferred that a fall in cardiac output was highly likely from the haemodynamic changes, and this is supported by the changes in ETCO 2 . The relationship between changes in cardiac output and ETCO 2 were initially described in relation to resuscitation 3, 4 . More recent studies 5, 6 have attempted to quantify the relationship. Shibutani et al 5 suggest that the proportional change in cardiac output is three times the proportional change in ETCO 2 .
There has been much less work on the clinical application of the effect of cardiac output changes on volatile agent kinetics than the effect of these changes on ETCO 2 . A trend towards the predicted relationship is illustrated by our cases. In clinical practice, cardiac output changes are often not large enough to produce significant changes in volatile agent kinetics 7 . Watt et al 8 , using a system which measured the amount of enflurane required to maintain a constant end-tidal value in a closed loop system, found that changes in enflurane consumption more closely related to cardiac output changes than ETCO 2 . They were unable to quantify the relationship but suggested that observation of trends in an individual patient is useful.
These clinical studies support our modelling work which suggests that the relationship between cardiac output and the uptake of volatile anaesthetic agents is difficult to quantify 9 and that a change in cardiac output of about 30 to 40% is needed to produce a detectable change in end-tidal values of isoflurane and enflurane 1, 2 . The magnitude of the change that can be detected is a function of the volatile agent's solubility in both blood and tissues 2 with an "optimum" blood gas partition coefficient in the range 1.5 to 2.5 1, 2, 10 . With sevoflurane a cardiac output change of 55% is needed to produce a detectable change in the end-tidal concentration 2 . The relationship between cardiac output and F E′ volatile (and ETCO 2 ) may also be affected by other factors such as associated changes in physiological dead space and perfusion of individual tissues. Anaesthesia and Intensive Care, Vol. 29, No. 5, October 2001 Observation of agent analyser displays can assist anaesthetists in understanding the kinetics of volatile anaesthetic agents. These analysers give a real time display of the effect of various changes on the kinetics of these agents. We suggest that although the F ET /F I diagram can summarize, for example, the effect of two different cardiac outputs, it is less useful in a clinical setting where a patient is changing between the states represented on such a diagram. We find a descriptive approach to volatile anaesthetic uptake based on Equation 1 and mass movement between compartments more useful. This approach considers the factors tending to add or remove volatile agent from each compartment and is illustrated in Table 1 . This approach to volatile kinetics demonstrates the effects of physiological changes and also illustrates the effect of external factors such as changes in fresh gas flow. For each compartment, if there is no removal of agent and the inputs remain constant, there will then be an exponential wash-in of agent if the anaesthetic parameters remain constant. Drug is removed from each compartment at the rate of "uptake" into the next compartment. This approach is commonly used in modelling anaesthetic uptake and distribution [11] [12] [13] .
If the tissue compartments are grouped so that there is an effect site compartment (the brain) and a second compartment (other tissue compartment) both connected to a central (blood) compartment, the model is similar to a standard three-compartment pharmacokinetic model. This illustrates that many principles, such as context sensitive decrement times, that are applied to injectable drugs are also applicable to volatile anaesthetics.
We have presented three patients in whom a significant haemodynamic change was accompanied by a noticeable change in end-tidal volatile anaesthetic and in ETCO 2 . The change in end-tidal volatile agent is predictable when the kinetics of the volatile agents are understood. We suggest that teaching the kinetics of these agents based on the equation above may improve appreciation of the effect of various physiological changes and interventions. Clinically an unexplained change in end-tidal concentration of a volatile agent may signify a large change in cardiac output, particularly if associated with an opposite change in ETCO 2 . During uptake increasing the factors listed for each compartment increase the amount of drug transfer to that compartment. The mass of drug in each compartment is reduced by transfer to the next compartment.
